All of the product reviews listed on this website are real reviews from real users. Recommended brands are selected solely based on merit. Our vetting process includes analysis of product quality based on third party lab reports, customer service quality and responsiveness, industry reputation, company longevity and customer feedback. Per FTC guidelines, we do participate in the affiliate programs of some but not all of the recommended brands whereby we receive a small commission on purchases made through links on this website. Any references to third party products, prices or websites referenced in this group are subject to change without notice.
In one survey, parents of children who suffer from treatment-resistant epilepsy and use CBD were asked about the benefits. 19 parents were included, 84% of which said that CBD reduced the frequency of seizures. Two parents said that CBD completely resolved seizures. Parents also reported improved alertness, sleep, and mood. Some side effects were drowsiness and fatigue .
Success stories like Oliver’s are everywhere, but there’s not a lot of data to back up those results. That’s because CBD comes from cannabis and, like nearly all other parts of the plant, is categorized by the Drug Enforcement Agency (DEA) as a Schedule 1 drug—the most restrictive classification. (Others on that list: heroin, Ecstasy, and peyote.) This classification, which cannabis advocates have tried for years to change, keeps cannabis-derived products, including CBD, from being properly studied in the U.S.